Acerta Pharma is a European R&D centre of the AstraZeneca Group, dedicated to the discovery and development of novel innovative medicines for the treatment of haematological malignancies
Acerta Pharma is a European R&D centre of the AstraZeneca Group, dedicated to the discovery and development of novel innovative medicines for the treatment of haematological malignancies. The company focuses on developing targeted small molecule therapies for cancer, leveraging unique covalent technology.